[Mitochondria in Cancer and Immunity].
1/5 보강
Mitochondria are multifunctional organelles responsible not only for ATP production via oxidative phosphorylation but also for a wide range of cellular activities, including biosynthesis, redox regula
APA
Taki T, Morinaga T, Togashi Y (2026). [Mitochondria in Cancer and Immunity].. Gan to kagaku ryoho. Cancer & chemotherapy, 53(2), 73-79.
MLA
Taki T, et al.. "[Mitochondria in Cancer and Immunity].." Gan to kagaku ryoho. Cancer & chemotherapy, vol. 53, no. 2, 2026, pp. 73-79.
PMID
41748505 ↗
Abstract 한글 요약
Mitochondria are multifunctional organelles responsible not only for ATP production via oxidative phosphorylation but also for a wide range of cellular activities, including biosynthesis, redox regulation, signal transduction, and the control of apoptosis. In both cancer and immune cells, mitochondrial function plays various roles that extend beyond mere energy production. While cancer cells are known for the Warburg effect‒an enhanced glycolysis even in the presence of oxygen-they also actively utilize mitochondrial metabolism to fuel tumor progression. Furthermore, mutations in mitochondrial DNA(mtDNA) and alterations in nuclear genes encoding mitochondrial proteins contribute to tumorigenesis through various mechanisms, such as epigenetic modifications and the evasion of apoptosis. In immune cells, such as T cells and macrophages, mitochondrial metabolism is crucial for their differentiation and functional regulation. Key processes such as T cell activation, memory formation, and exhaustion, as well as macrophage functional polarization and inflammatory responses, are tightly linked to mitochondrial functional states. Recently, intercellular mitochondrial transfer within the tumor microenvironment has emerged as a significant phenomenon. Cancer cells can acquire mitochondria from surrounding cells to enhance their metabolic capacity and therapeutic resistance. Conversely, the transfer of mitochondria from cancer cells to T cells has been shown to suppress antitumor immune responses through metabolic dysfunction and homoplasmic replacement of T cell mtDNA. Based on these findings, therapeutic strategies targeting mitochondria are under investigation. These include inhibiting mitochondrial metabolism in cancer cells, boosting mitochondrial metabolism in T cells, and blocking intercellular mitochondrial transfer. Although preclinical studies have yielded promising results, further research is necessary to establish effective clinical therapies that can precisely modulate the complex metabolic interplay between cancer and immune cells.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.